2014-004757-14
Safety, and Immunogenicity of Two Influenza Vaccines in Healthy Subjects 3 to 64 Years Old
Novartis Vaccines and Diagnostics S.r.l.·EU Clinical Trials Register
Study focus
- Disease/Condition
- Influenza
Sponsor & location
- Primary sponsor
- Novartis Vaccines and Diagnostics S.r.l.
- Funder
- Novartis Vaccines
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
Primary outcome
1. Percentage of subjects achieving seroconversion1 or significant increase2 in antibody titer at Day 22 for age group 3;
ICD-10 classifications
Influenza and pneumoniaInfluenza due to identified seasonal influenza virusInfluenza with other manifestations, seasonal influenza virus identifiedInfluenza with pneumonia, seasonal influenza virus identifiedInfluenza due to identified zoonotic or pandemic influenza virus
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2014-004757-14
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2014-004757-14 through Pure Global AI's free database. This phase not specified trial is sponsored by Novartis Vaccines and Diagnostics S.r.l. and is currently status unknown. The study focuses on Influenza.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.